期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

纤溶活性与2型糖尿病及其大血管病变 被引量：3

下载PDF
导出
摘要 组织型纤溶酶原激活剂(tPA)和纤溶酶原激活物抑制剂-1(PAI-1)是纤溶系统的主要调控因子。2型糖尿病患者高血糖、高胰岛素血症、脂代谢紊乱、炎症反应、肥胖等多种因素可引起血浆tPA水平降低、PAI-1水平升高。纤溶活性的降低参与了大血管病变的发生、发展。提高纤溶活性的综合治疗将对防治糖尿病大血管并发症起一定作用。
作者 张悦 苏胜偶
机构地区 河北医科大学附属第二医院内分泌科
出处 《国外医学（内分泌学分册）》 2005年第B04期42-44,共3页 Foreign Medical Sciences(Section of Endocrinology)
关键词 纤溶活性 2型糖尿病 大血管病变 高血糖 高胰岛素血症 脂代谢紊乱
分类号 R587.2 [医药卫生—内分泌]
  • 相关文献

参考文献18

  • 1Leurs PB, Stolk RP, Hamulyak K, et al. Tissue factor pathway inhibitor and endothelium-dependent hemostatic factors in elderly individuls with normal or impaired glucose tolerance and type 2 diabetes. Diabetes Care,2002,25:1340-1345.
  • 2Lapolla A, Piarulli F, Sartore G, et al. Peripheral artery disease in type 2diabetes: the role of fibrinolysis. Thromb Haemost, 2003,89: 91-96.
  • 3Lee HS, Moon KC, Song CY, et al. Glycated albumin activates PAI-1transcription through Smad DNA binding sites in mesangial cells. Am J Physiol Renal Physiol, 2004,287: 665-672.
  • 4Pandolfi A, Giaccari A, Cilli C, et al. Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrionlytic activity and increase plasminogen activator inhibitor type 1 in the rat. Acta Diabetol, 2001,38:71-76.
  • 5Suzuki M, Akimoto K, Hattori Y. Glucose upregulates plasminogen activator inhibitor-1 gene expression in vascular smooth muscle cells. Life Sci, 2002,72: 59-66.
  • 6Samad F, Pandey M, Bell PA, et al. Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes. Mol Med,2000,6: 680-692.
  • 7Banfi C, Eriksson P, Giandomenico G, et al. Transcriptional regulation of plasminngen activator inhibitor type 1 gene by insulin: insights into the signaling pathway. Diabetes,2001,50:1522-1530.
  • 8Nordt TK, Bode C, Sobel BE. Stimulation in vivo of expression of intraabdominal adipose tissue plasminogen activator inhibitor type 1 by proinsulin. Diabetologia,2001,44:1121-1124.
  • 9Krebs M, Geiger M, Polak K, et al. Increased plasma levels of plasminogen activator inhibitor-1 and soluble vascular cell adhesion molecule after triacylglycerol infusion in man. Thromb Haemost, 2003,90: 422-428.
  • 10Zhang J, Ren S, Shen GX. Glycation amplifies lipoprotein( a)-induced alterations in the generation of fibrinolytic regulators from human vascular endothelial cells. Atherosclerosis,2000,150:299-308.

同被引文献18

  • 1陶少平.糖尿病肾病的早期诊治进展[J].中华全科医学,2003,5(1):61-63. 被引量：11
  • 2吴国仲,吴永贵.糖尿病肾病发病炎症机制研究进展[J].国外医学（泌尿系统分册）,2005,25(3):363-367. 被引量：46
  • 3Koji Y,Kyosuke T,Tetsuhito K,et al.Aging and plasminogen activatorinhibitor-1(PAI-1)regulation:implication in the pathogenesis of throm-botic disorders in the elderly.Cardiovascular Research,2005,66(3):226-285.
  • 4Navarro JF,Mora C,Gomez M,et al.Influence of renal involvemention peripheral blood mononuclear cell expression bchaviour of tumour necrosis factor-alpha and interlcukin -6 in type 2 diabetic patients.Nephrol Dial Tmnsplant,2008,23(3):919-926.
  • 5Galajda P,Martinda E,Mokan M,et al.Endothelial markers in diabetes Mellitus[J].Thromb Res,1997,85:63～65.
  • 6Estelles A,Tormo G,Aznar J,et al.Reduced fibrinolytie octivity in cornary heart disease in dasal condition and ajter exercise[J].Thomb Res,1985,40:373～378.
  • 7Cardona F, Tinahones FJ, collantes E, et al. The elevated prevalence of apolipoprotein E2 in patients with gout is associated with reduced renal excretion of urates[ J]. Rheum, 2003, 42 : 468-472.
  • 8Estelles A, Tormo G, Aznar J, et al. Reduced flbfinolytlc octivity in comary heart disease in dasal condition and ajter exercise [ J ]. Thomb Res, 1985, 40: 373-378.
  • 9田润华,余云云,申黎艳,葛银林.新诊2型糖尿病患者血清相关炎症因子与HbAlc联检的临床意义[J].放射免疫学杂志,2007,20(5):430-432. 被引量：2
  • 10陈良华.降低胆固醇在冠心病防治中的作用[J].国外医学（内科学分册）,1997,24(7):291-294. 被引量：33

引证文献3

二级引证文献5

国外医学（内分泌学分册）
2005年 第B04期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部